Results 41 to 50 of about 391 (114)

Treatment of generalized pustular psoriasis with Spesolimab: a case report and literature review

Pifu-xingbing zhenliaoxue zazhi
Objective To evaluate the efficacy and safety of Spesolimab in the treatment of generalized pustular psoriasis(GPP). Methods A 30 years old female with GPP was intravenously given 900 mg of Spesolimab once.
Xiaoqian LIANG, Zexi MI, Yaohan XU, Yongfeng CHEN   +3 more
doaj   +1 more source

A case of generalized pustular psoriasis

Vestnik Dermatologii i Venerologii, 2017
The article presents a clinical case of generalized pustular psoriasis. Complex therapy features for this rare and severe type of psoriasis are described.
V. A. Oklopkov, O. V. Pravdina, A. A. Chermoschentsev, T. V. Repina, E. I. Poleshuk, V. G. Gudoshnik, R. V. Gorodilov   +6 more
doaj   +1 more source

Methotrexate and Adalimumab Combination Efficacy in 4-year-old Child with Generalized Pustular Psoriasis: Case Study

Вопросы современной педиатрии
Background. Generalized pustular psoriasis management in children is a topical issue due to limited use and efficacy of traditional immunodepressants, absence of registered genetically engineered biologic drugs.
Nikolay N. Murashkin, Mariya A. Leonova, Alexandra Yu. Kulishova, Anna V. Skibitskaya, Alexandr I. Materikin, Roman V. Epishev, Dmitry V. Fedorov, Roman A. Ivanov, Ekaterina S. Pavlova, Leonid A. Opryatin   +9 more
doaj   +1 more source

Consensus‐based Guideline on tinea capitis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The consensus‐based guideline developed under the auspices of the German Dermatological Society (DDG) is intended to provide physicians with a structured framework for clinical decision‐making in the management of patients with tinea capitis and to contribute to improved diagnostic accuracy, treatment adherence, and prevention. Tinea capitis is
Peter Mayser, Dietrich Abeck, Philipp P. Bosshard, Jochen Brasch, Georg Daeschlein, Isaak Effendy, Yvonne Gräser, Peter Höger, Julia Huynh, Maria Kinberger, Annette Kolb‐Mäurer, Katharina Antonia Langen, Bartosz Malisiewicz, Alexander Nast, Hagen Ott, Christin Pelzer, Dieter Reinel, Martin Schaller, Silke Uhrlaß, Pietro Nenoff   +19 more
wiley   +1 more source

Pustular psoriasis: pathophysiology and current treatment perspectives

Psoriasis: Targets and Therapy, 2016
Katie E Benjegerdes,1 Kimberly Hyde,2 Dario Kivelevitch,3 Bobbak Mansouri1,4 1Texas A&M Health Science Center College of Medicine, Temple, 2Texas A&M Health Science Center College of Medicine, Round Rock, 3Division of Dermatology, Baylor ...
Benjegerdes KE, Hyde K, Kivelevitch D, Mansouri B   +3 more
doaj  

Challenges of biological therapy in patients with pustular psoriasis coexisting with psoriatic arthritis

Przegląd Dermatologiczny, 2017
Introduction . Psoriasis is a chronic inflammatory skin disease affecting approximately 2–3% of the general population. It is a condition with immunological and genetic background, coexisting with psoriatic arthritis in about 25% of cases. Biologic drugs
Joanna Narbutt, Magdalena Trelińska, Anna Woźniacka, Irmina Olejniczak-Staruch, Aleksandra Lesiak   +4 more
doaj   +1 more source

Systemic Treatment and Outcome in Erythrodermic Psoriasis: A Retrospective Multicenter Study

International Journal of Dermatology, EarlyView.
This multicentre real‐world study illustrates the heterogeneity of systemic treatment approaches in erythrodermic psoriasis (EP) in Bavaria, Germany. Adverse events were more frequently observed with conventional therapies, whereas biologic therapies showed favorable outcomes.
Julian Kögel, Sandra Schuh, Julia Welzel, Michael Sticherling, Lukas Sollfrank, Carola Berking, Teodora Pumnea, Valerie Glatzel, Lars French, Felix Lauffer, Martin Valentin Vitus, Tilo Biedermann, Susanne Bauer, Michael Spindler, Mark Berneburg, Dennis Niebel   +15 more
wiley   +1 more source

Clinical analysis of secukinumab in the treatment of childhood generalized pustular psoriasis

Pifu-xingbing zhenliaoxue zazhi
Objective To explore the clinical efficacy and safety of secukinumab in the treatment of childhood generalized pustular psoriasis (GPP) in order to provide a new therapeutic strategy for childhood generalized pustular psoriasis.
Min YU, Zhanghong YING
doaj   +1 more source

Evaluation of Discontinuation and Re‐Initiation of Biologic Therapies in Psoriasis: Real‐World Data

International Journal of Dermatology, EarlyView.
The cumulative probability of remaining relapse‐free following biologic therapy discontinuation was 35.6%, 19%, 11.6%, and 9.1% at 6, 12, 18, and 24 months, respectively. Prolonged relapse durations were associated with a low baseline PASI score, the presence of a PASI 90 response at discontinuation, the absence of triggering factors, and the use of IL‐
Ahmet Taha Aydemir, Nihal Kundakcı
wiley   +1 more source

Spesolimab for the Treatment of Generalized Pustular Psoriasis

Drugs, 2023
Generalized pustular psoriasis (GPP) is a rare but severe skin inflammatory disorder characterized by the eruption of widespread sterile neutrophilic pustules, often accompanied by systemic inflammation. Given its life-threatening potential, GPP requires prompt accurate diagnosis and effective treatment, but its rarity and relapsing-remitting nature ...
Diana Bernardo, Diamant Thaçi, Tiago Torres   +2 more
openaire   +2 more sources